Ellie Rapps joined Hanson Wade in 2022 after studying Biological Sciences at university. Since joining the business, her primary focus has been the growth and development of Hanson Wade’s World CNS Event Series, working closely with industry leaders across neurodegenerative disease, neuropsychiatry, and drug delivery. Alongside her neuroscience expertise, Ellie has also overseen conferences within the dermatology, ophthalmology and CVRM therapy areas. She has also played a leading role in expanding Hanson Wade’s CNS portfolio internationally, driving growth across Europe and, more recently, supporting the portfolio’s expansion into Asia.